Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,562 | 4,791 | 1,821 | 306 | 8,898 |
| Depreciation Amortization | 1,345 | 995 | 672 | 347 | 1,435 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,172 |
| Accounts receivable | -37 | -2,488 | -1,172 | -907 | 439 |
| Other Working Capital | -2,012 | -5,311 | -1,379 | -1,717 | -1,010 |
| Other Operating Activity | 481 | 2,383 | 995 | 1,413 | -1,081 |
| Operating Cash Flow | $3,339 | $370 | $938 | $-558 | $6,508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,737 | -5,200 | -5,200 | -95 | -499 |
| Investing Cash Flow | $-5,737 | $-5,200 | $-5,200 | $-95 | $-499 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,439 | N/A | 14,550 | 12,000 | N/A |
| Debt Repayment | -12,240 | 14,550 | N/A | -104 | N/A |
| Other Financing Activity | -497 | -346 | -268 | 0 | -667 |
| Financing Cash Flow | $1,702 | $14,204 | $14,282 | $11,897 | $-667 |
| Beginning Cash Position | 8,940 | 8,940 | 8,940 | 8,940 | 3,598 |
| End Cash Position | 8,245 | 18,314 | 18,960 | 20,185 | 8,940 |
| Net Cash Flow | $-696 | $9,374 | $10,020 | $11,244 | $5,343 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,339 | 370 | 938 | -558 | 6,508 |
| Capital Expenditure | -5,737 | -5,200 | -5,200 | -95 | -499 |
| Free Cash Flow | -2,398 | -4,830 | -4,262 | -652 | 6,010 |